David Haldane
Overview
Explore the profile of David Haldane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meilleur C, Zhou J, Hoang L, Tyrrell G, Minion J, Van Caeseele P, et al.
J Med Microbiol
. 2025 Mar;
74(3).
PMID: 40071600
Invasive meningococcal disease (IMD) is a nationally notifiable illness in Canada due to its potential severity and transmissibility. Vaccination strategies differ by province/territory and are informed by changes in the...
2.
Wilke M, Mistry K, Thumbi D, Li X, Charlebois A, Cormier A, et al.
Can J Microbiol
. 2025 Mar;
PMID: 40030142
Ciprofloxacin is important for treatment of severe or invasive Salmonella infections in humans. As laboratories transition from phenotypic to genomics-based methods for determining ciprofloxacin non-susceptibility, it is important to define...
3.
Golden A, Griffith A, Tyrrell G, Kus J, McGeer A, Domingo M, et al.
Emerg Infect Dis
. 2024 Oct;
30(11):2409-2413.
PMID: 39428565
To determine invasive group A Streptococcus trends in Canada, we characterized emm1 isolates collected during 2018-2023. The percentage of hypervirulent M1 lineage isolates increased significantly, from 22.1% in 2018 to...
4.
Griffith A, Golden A, Lefebvre B, McGeer A, Tyrrell G, Zhanel G, et al.
Can Commun Dis Rep
. 2024 Jun;
50(5):121-134.
PMID: 38835503
Background: Invasive pneumococcal disease (IPD, ) has been a nationally notifiable disease in Canada since 2000. The use of conjugate vaccines has caused a shift in the distribution of serotypes...
5.
Golden A, Griffith A, Tyrrell G, Kus J, McGeer A, Domingo M, et al.
Can Commun Dis Rep
. 2024 Jun;
50(5):135-143.
PMID: 38835501
Background: Invasive group A streptococcal (iGAS, ) disease has been a nationally notifiable disease in Canada since 2000. This report summarizes the demographics, types, and antimicrobial resistance of iGAS isolates...
6.
Sawatzky P, Lefebvre B, Diggle M, Hoang L, Wong J, Patel S, et al.
Can Commun Dis Rep
. 2024 Mar;
49(9):388-397.
PMID: 38463902
Background: In Canada, gonorrhea is the second most prevalent bacterial sexually transmitted infection. The Gonococcal Antimicrobial Surveillance Programme (GASP - Canada), a passive surveillance system monitoring antimicrobial resistance in in...
7.
Thorington R, Sawatzky P, Lefebvre B, Diggle M, Hoang L, Patel S, et al.
Can Commun Dis Rep
. 2024 Feb;
48(11-12):571-579.
PMID: 38298531
Background: The Gonococcal Antimicrobial Surveillance Programme is a passive surveillance system that has monitored antimicrobial resistance in in Canada since the 1980s. This article summarizes the demographics, antimicrobial resistances and...
8.
Golden A, Griffith A, Demczuk W, Lefebvre B, McGeer A, Tyrrell G, et al.
Can Commun Dis Rep
. 2023 Dec;
48(9):396-406.
PMID: 38124782
Background: Invasive pneumococcal disease (IPD), which is caused by , has been a nationally notifiable disease in Canada since 2000. The use of conjugate vaccines has markedly decreased the incidence...
9.
Golden A, Griffith A, Demczuk W, Tyrrell G, Kus J, McGeer A, et al.
Can Commun Dis Rep
. 2023 Dec;
48(9):407-414.
PMID: 38106647
Background: Invasive group A streptococcal (iGAS) disease (caused by ) has been a nationally notifiable disease in Canada since 2000. This report summarizes the demographics, types and antimicrobial resistance of...
10.
Golden A, Adam H, Karlowsky J, Baxter M, Schellenberg J, Martin I, et al.
J Antimicrob Chemother
. 2023 May;
78(Suppl 1):i26-i36.
PMID: 37130587
Objectives: To investigate the lineages and genomic antimicrobial resistance (AMR) determinants of the 10 most common pneumococcal serotypes identified in Canada during the five most recent years of the SAVE...